REYON Trademark

Trademark Overview


On Thursday, October 18, 2018, a trademark application was filed for REYON with the United States Patent and Trademark Office. The USPTO has given the REYON trademark a serial number of 88160759. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 13, 2021. This trademark is owned by Reyon Pharmaceutical Co., Ltd. The REYON trademark is filed in the Pharmaceutical Products category with the following description:

Anaesthetics; Anti-cancer preparations; Anti-inflammatory and antipyretic preparations; Antibiotics; Antihistamines; Antivirals; Cardiovascular pharmaceuticals; Cardiovascular treatment preparations; Diagnostic preparations for medical purposes; Diagnostic reagents and contrast media for medical use; Hormonal preparations; Hormones for medical purposes; Ocular pharmaceuticals; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparat...
reyon

General Information


Serial Number88160759
Word MarkREYON
Filing DateThursday, October 18, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 13, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2019

Trademark Statements


Goods and ServicesAnaesthetics; Anti-cancer preparations; Anti-inflammatory and antipyretic preparations; Antibiotics; Antihistamines; Antivirals; Cardiovascular pharmaceuticals; Cardiovascular treatment preparations; Diagnostic preparations for medical purposes; Diagnostic reagents and contrast media for medical use; Hormonal preparations; Hormones for medical purposes; Ocular pharmaceuticals; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for use in urology; Pharmaceutical products for treating respiratory diseases; Psychotropics; Therapeutic vaccines; Tumor suppressing agents; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 31, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameReyon Pharmaceutical Co., Ltd
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeoul 06176
KR

Party NameReyon Pharmaceutical Co., Ltd
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeoul
KR

Trademark Events


Event DateEvent Description
Monday, December 13, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 13, 2021ABANDONMENT - NO USE STATEMENT FILED
Friday, May 7, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 5, 2021EXTENSION 4 GRANTED
Wednesday, May 5, 2021EXTENSION 4 FILED
Wednesday, May 5, 2021TEAS EXTENSION RECEIVED
Tuesday, November 3, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 30, 2020EXTENSION 3 GRANTED
Friday, October 30, 2020EXTENSION 3 FILED
Friday, October 30, 2020TEAS EXTENSION RECEIVED
Tuesday, April 14, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 10, 2020EXTENSION 2 GRANTED
Friday, April 10, 2020EXTENSION 2 FILED
Friday, April 10, 2020TEAS EXTENSION RECEIVED
Tuesday, October 22, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 18, 2019EXTENSION 1 GRANTED
Friday, October 18, 2019EXTENSION 1 FILED
Friday, October 18, 2019TEAS EXTENSION RECEIVED
Tuesday, May 7, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 12, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 12, 2019PUBLISHED FOR OPPOSITION
Wednesday, February 20, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 28, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 28, 2019ASSIGNED TO EXAMINER
Wednesday, October 31, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, October 22, 2018NEW APPLICATION ENTERED IN TRAM